key: cord-0954273-r23l0saz
authors: Chatzimanolakis, M.; Weber, P.; Arampatzis, G.; Wampaumllchli, D.; Kicic, I.; Karnakov, P.; Papadimitriou, C.; Koumoutsakos, P.
title: Optimal Allocation of Limited Test Resources for the Quantification of COVID-19 Infections
date: 2020-11-10
journal: nan
DOI: 10.1101/2020.11.09.20228320
sha: 4bdc5ae3f1f55d0fa20034051b8ef36e454a32f9
doc_id: 954273
cord_uid: r23l0saz

The systematic identification of infected individuals is critical for the containment of the COVID-19 pandemic. Presently, the spread of the disease is mostly quantified by the reported numbers of infections, hospitalizations, recoveries and deaths; these quantities inform epidemiology models that provide forecasts for the spread of the epidemic and guide policy making. The veracity of these forecasts depends on the discrepancy between the numbers of reported and unreported, yet infectious, individuals. We combine Bayesian experimental design with an epidemiology model and propose a methodology for the optimal allocation of limited testing resources in space and time, which maximizes the information gain for such unreported infections. The proposed approach is applicable at the onset and spreading of the epidemic and can forewarn for a possible recurrence of the disease after relaxation of interventions. We examine its application in Switzerland; the open source software is, however, readily adaptable to countries around the world. We find that following the proposed methodology can lead to vastly less uncertain predictions for the spread of the disease. Estimates of the effective reproduction number and of the future number of unreported infections are improved, which in turn can provide timely and systematic guidance for the effective identification of infectious individuals and for decision-making.

The identification of unreported individuals infected by the SARS-CoV-2 virus is critical for the quantification, forecasting and planning of interventions during the COVID-19 pandemic [1] . Presently the spread of the disease is mostly quantified by the reported numbers of infections, hospitalizations, recoveries and 5 deaths [2] . These quantities inform epidemiology models that provide short term forecasts for the spread of the epidemic, help quantify the role of possible interventions and guide policy making. The veracity of these forecasts depends on the discrepancy between the numbers of reported and unreported, yet infectious, individuals. 10 In recent months the estimation of unreported infections has been the subject of several testing campaigns [3, 4] . While there is valuable information being gathered, their estimates rely on testing individuals that are either already symptomatic or have been selected based on certain criteria (hospital visits, airport arrivals, geographic vicinity to researchers, etc.). Generic, randomized tests 15 of the population are broadly applied but they have been hampered either by delays [5] or by insufficient numbers of test kits [6] . There is broad recognition that efficient testing strategies are critical for the timely identification of infectious individuals and the optimal allocation of resources [7] . However, targeted testing entails bias while randomized tests require access to a high percentage 20 of the population with commensurate high costs. The quality of the data as well as the ways they are incorporated in the epidemiology models is critical for their predictions and for estimating their uncertainties [8] . Having the capability to minimize these uncertainties by suitably distributing in space and time a given number of test kits is the subject of this work. This optimal allocation of testing resources and the respective increase of the fidelity of forecasting models are essential to effective policy making throughout the pandemic.

Here, we present a methodology for the OPtimal Allocation of LImited Testing resourceS (OPALITS) that maximizes the information gain over any prior knowledge regarding infections. The method relies on forecasts by epidemio-30 logical models with parameters adjusted through Bayesian inference as data become available through suitable surveys [9] . The forecasts are combined with Bayesian experimental design [10, 11, 12] to determine the optimal test allocation in space and time for various objectives (minimize prediction uncertainty, maximize information gain of unreported infections). We emphasize that the 35 proposed OPALITS is applicable in all stages of the pandemic, regardless of the availability of data.

We employ the SEI r I u R model [13] that quantifies the spread of a disease in a country's population distributed in a number of communities that are interacting through mobility networks. The SEI r I u R model predicts the number 40 of susceptible (S), exposed (E), infectious reported (I r ), unreported (I u ), and removed (R) individuals from the population. Here we focus on Switzerland and consider its cantons as the respective communities. The model parameters are: the relative transmission rate between reported and unreported infectious individuals (µ), the virus latency period (Z), the infectious period (D) and the 45 reporting rate (α). The transmission rate (β) and the mobility factor (θ) are considered to be time dependent in order to account for government interventions. For all stages of the epidemic, the respective uncertainties of the model parameters are quantified and propagated using Bayesian inference. At the onset of the epidemic, the uncertainty is quantified through prior probability where C and T are the set of all available locations and days, respectively.

In this paper a survey aims to determine the number of unreported infectious individuals in a particular location on a particular day. In the following we assume limited testing resources, where N test-kits are available and each test- The results of the survey in a canton enable the estimation of a desired quan-5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint tity of interest, such as the size of the unreported infected population (I u ). The number of samples needed to estimate population proportions within a given confidence interval, error tolerance, and probability of proportion is given by Cochran's formula [9] corrected for a finite population size. Using Cochran's 110 formula with confidence level 99%, error tolerance 1% and probability of infection 0.1 we find that the samples that would be required to survey the largest Swiss canton (of Zurich) are approximately 5950. All the other cantons need up to 14% less samples with the exception of the smallest canton that needs 27% less samples (figure S7 of the Supplementary Information). Hence we assume the 115 minimum sample size is the same for all cantons. Assuming random sampling of a population with higher probability (up to 0.9) of infection or requiring tighter error bounds, would have implied even more samples according to Cochran's formula. We note that as of October 2020, 1500 tests per one million people are performed on a daily basis in Switzerland [16] . This amounts to approximately 120 460 individual tests per canton, which is about an order of magnitude less than what would be required from Cochrans's formula for an informative random sampling. In turn, by using the proposed OPALITS we can compensate for this lack of test kits with an optimal and systematic process.

We outline the application of the proposed approach to a country with dis-125 tinct administrative units (cantons in the case of Switzerland) (see figure 1 ).

First, we determine how many cantons will be surveyed, given the number of available test-kits N . Then, the sequential optimization of the expected utility function is performed (see Materials and Methods) to identify optimal survey locations (cantons). We then distribute the test-kits to the identified cantons The expected information gain of a particular strategy for selecting the sur-6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint vey locations/times s is quantified by a utility functionÛ (s) [15] . The maximum of this function corresponds to an optimal strategy that yields the most information about the quantities of interest. The expected utility function can be 140 understood as a measure of the difference between prior knowledge of the model parameters and the posterior knowledge, after surveys have been conducted in a set of locations and dates. Given such a set, the utility function estimates the expected difference, equivalently the information gain, by taking the expectation over all possible survey results.

The OPALITS relies on forecasts by suitable epidemiological models. In turn, these forecasts rely on prior information and their predictions are further adjusted as data become available in a Bayesian inference framework [17] .

The set of Ordinary Differential Equations (ODEs) describing the SEI r I u R model [13] are integrated to produce the model output. The uncertainty of the 150 model output and its discrepancy from the available data is quantified through a parametrized error model. The resulting stochastic model and its quantified uncertainties are then used to identify the optimal spatio-temporal allocation of limited test resources. information for estimating the model parameters.

8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; Case 2: Exponential spreading and optimal testing strategy during non -pharmaceutical interventions. When the spreading of the coronavirus entered an exponential growth stage, several governments (including the Swiss) decided to take non-pharmaceutical interventions such as requesting social distancing, 200 closing schools and restaurants, or ordering a complete lockdown in order to contain the epidemic. Here, the goal of the OPALITS is to propose surveys that would help to better assess the effectiveness of these interventions.

In this case, probability distributions of model parameters are informed using data from the existing spread of the COVID-19. The daily reported infections in CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint Table S2 . If only a single canton were to be selected(due to limited availability of test-kits in the country), then a survey in the canton of Vaud carried out on the 30 th of March were to be preferred over surveys in either of 220 the cantons of Zurich, Bern or Geneva (blue in figure 4 ). If two surveys could be afforded, the OPALITS methodology proposes to carry them out in the same canton (Vaud) on the 17 th and on the 30 th March (blue and green in figure 4 ).

Note that the canton of Zurich, ranked as the next preferred canton for a single survey (blue in figure 4 ), is not selected by the methodology since part of the 225 information that would be gained from testing is already contained in surveys performed in Vaud. In case more test kits were available, in addition to the two tests in Vaud, the optimal location and time for a third survey would have been the canton of Grisons on the 30 th of March (yellow in figure 4 ). The canton of Zurich is proposed as the fourth location to be surveyed on the 30 th of March 230 as well. However, the information gain from the fourth survey in the canton of Zurich is approximately 10% of the total information gained from the surveys carried optimally in the first three cantons.

The results suggest that surveys in two locations/times provide significant information regarding assessing the effectiveness of interventions. Further tests 235 on more locations/times did not add substantial information. It is evident that a trade-off between the required information gain and cost of testing are decisive for the number of necessary surveys and respective test kits. First, Bayesian inference is performed with data available from February 11 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint The maximum gain of information is plotted on the map of Switzerland using an exponential colormap. Here blue corresponds to taking one survey, green to adding a second, yellow to a third and red to a fourth. Below the map we plot the magnitude of the expected information gain of each survey, along with the optimal measurement dates per canton.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (Tables S3 and S4 ). Given that tests should be carried out in four locations and times, the methodology promotes optimal surveys for two different times, within a week, in the cantons of Zurich and Vaud. First, surveys should be performed in Zurich, providing high information gain for both considered cases.

The next two surveys are to be performed in Zurich and Vaud, with a rank that 265 depends on the considered case, while the fourth test should be performed in Vaud. We find that the information gain from the last test is approximately 10% of the cumulative information gain from the first three surveys. The number of surveys can be then selected according to the available test-kits N .

Case 4: Effectiveness of Optimal Testing. We demonstrate the importance of 270 following the OPALITS by comparing it with a non-specific testing campaign that is based on heuristics. We first re-examine the situation at the start of an epidemic and assume that the available resources allow for two surveys. Surveys are simulated by evaluating the epidemiological model with the maximum a-13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. are found by sampling the model parameters using nested sampling [14] .

The resulting one-and two-dimensional marginalized posterior distributions for both strategies are shown in figure 6 . We note that the dispersion coefficient with a confidence interval that is up to four times narrower than the one from a non-specific strategy. The same figure also shows the relative histogram plots for the effective reproduction number, which for the employed model is given [13] . Not only is the histogram more peaked, when data is optimally collected, but also the mean value of the two histograms 305 15 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint the survey following the optimal testing strategy, gray the one for the non-specific strategy.

The lower half and upper half show the samples of the joint distribution of two parameters for the optimal and the non-specific strategy respectively. Here black indicates low density and yellow high density.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; is different. When data is optimally collected, the found mean value for the effective reproduction number is 2.1, whereas when the non-specific strategy is followed the average value is 3.2. A mean value of 3.2 could lead to more strict non-pharmaceutical interventions, which might prove unnecessary and harmful for the economy. 

We introduce a systematic approach to identify optimal times and locations for epidemiological surveys to quantify infectious individuals in a country's population during the COVID-19 epidemic. The proposed OPALITS methodology 320 exploits prior information and available data to maximize the expected information gain in quantities of interest and to minimize uncertainties in the forecasts of epidemiological models.

The present study addresses the need for an accurate assessment of COVID-19 infections [21] and it is shown to be far more accurate than the currently 325 applied random testing. The proposed methodology is, to the best of our knowledge, the first method to propose an optimal spatio-temporal allocation of limited test-kit resources . A first study for the estimate of unobserved COVID-19

infections [5] in the USA indicated that early testing would have decreased the surveillance gap during a critical phase of the epidemic. More recently a num-330 ber of studies have emerged that address the optimal allocation of resources.

The "Test and Contain" process suggested in [7] addresses an idealized population of 10'000 and solves an allocation problem using predictions of the SIR model. They assume an isolation of the positively identified individuals and 17 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint with data obtained by optimal (purple) and non-specific testing (gray). Down: Relative frequency histograms for effective reproduction number, predicted with data obtained by optimal (purple) and non-specific testing (gray).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint showed that just one test a day can reduce the peak of infected individuals 335 by 27%. This study is similar to ours in casting the test allocation problem in an optimization framework using linear programming in contrast to information maximization that we propose. However, their approach is not data informed and does not address a realistic country scenario. Another study [22] focused on test-kit allocation in the Philippines. They use a statistical approach 340 and non-linear programming to determine the optimal percentage allocation of COVID-19 test-kits among accredited testing centers in the Philippines aiming for an equitable chance to all infected individuals to be tested. Their goal of optimal percentage allocation differs from ours that is optimal space and time allocation of test-kits.

The proposed method is demonstrated by focusing on the outbreak of the epidemic in Switzerland. We compare OPALITS with random testing and demonstrate its advantages in producing forecasts with far reduced uncertainties. We note that the existing testing capacity of 1500 tests per million people in Switzerland can be better allocated than the ongoing random testing. More-350 over we show that the present methodology will be of particular importance to countries with testing capacity that is far lower than that of Switzerland [16].

The methodology relies on Bayesian experimental design using prior information and available data of reported infections along with forecasts from the SEI r I u R model. We compute the optimal testing strategy for three phases of CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint lower than 1%, [24] .

During the period of non-pharmaceutical interventions the proposed strategy would help quantify their effectiveness assisting decision making for further interventions or retraction of measures that may be harmful to the economy.

In this study, available data for the daily reported infections prior to any inter- We remark that the proposed OPALITS does not depend on a particular type of data/model or to the country of Switzerland. The open source code is modular, scalable and readily adaptable to different scenarios for the epidemic and countries around the world. We believe that the present work can be a 395 valuable tool for decision makers to allocate resources efficiently for testing the 20 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint population, providing a reliable quantification of the spread of the disease and designing effective interventions.

We acknowledge discussions with Fabian Wermelinger, Lucas Amoudruz, 

The authors have no competing interests.

All data is available in the manuscript or the Supplementary Materials. The code is available under https://github.com/cselab/optimal-testing.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. launch-of-the-first-rapid-test-for-covid-19-on-the-swiss-market; 2020. Online.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. 

The optimal time (day) and location (canton) for surveying a population to detect infectious individuals is determined via Bayesian optimal experimental design [1] . This optimal testing allocation (OPALITS) relies on combining Bayesian inference and utility theory with forecasting models of the epidemic.

We remark that the OPALITS does not depend on a particular epidemiological model or type of data. The methodology is applicable at all stages of the epidemic (inception to re-occurrence). It can operate without data at the early stages of the pandemic and takes advantage of data available at later stages of the pandemic. The methodology is rendered computationally efficient using a sequential optimization algorithm [2] .

Bayesian Inference from randomized testing. We consider a testing campaign including a set (s) of surveys s i = (k i , t i ), i = 1, . . . M y performed in location k i ∈ C and on day t i ∈ T . These surveys measure a quantity of interest (QoI), that is denoted by y(s) = (y 1 , . . . , y My ). Here, y i is the number of unreported * These authors contributed equally to this work. * * Corresponding author (petros@seas.harvard.edu) Preprint submitted to Medrxiv November 9, 2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint infectious individuals, measured through survey s i . The QoI can be predicted by a model g(s, ϑ, ϑ) (here the SEI r I u R epidemiological model) that depends on parameters of interest ϑ ∈ R N and nuisance parameters ϑ ∈ RÑ . The distinction between model and nuisance parameters is discussed in later sections.

We note that both sets of parameters are uncertain and the proposed method aims to reduce the uncertainty only in the parameters of interest.

A stochastic error term ε(s) links the model prediction with the QoI y(s) = g(s, ϑ, ϑ) + ε(s) .

(

The error ε(s) is assumed to follow a zero-mean multivariate normal distribution N (0, Σ) with covariance matrix Σ ∈ R My×My . The elements of the covariance matrix (Σ s,s ′ ) correspond to surveys taken at s = (k, t) and s ′ = (k ′ , t ′ ) and are given by

where δ kk ′ is the Kronecker delta, which is 1 for k = k ′ and 0 otherwise. 

where s i = (i, t). The parameter c ∈ [0, 0.25] is considered a model parameter.

The expectation E ϑ, ϑ [ · ] is taken with respect to all parameters ϑ and ϑ that follow the prior probability distribution with density p(ϑ, ϑ) = p(ϑ)p( ϑ).

Under these assumptions, the conditional probability of y on ϑ, ϑ and s is given by

2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint where |Σ(s)| is the determinant of the covariance matrix and z = y(s) − g(s, ϑ, ϑ).

In the present study, the QoI measured by a survey is the number of unreported infectious individuals in a particular canton on a particular date. This implicitly assumes that there no restrictions on when the survey can be conducted and that there are no observational delays, which means the the QoI is instantaneously obtained. Both assumptions are not restrictive however. Restrictions on the possible survey dates can be accounted for by simply excluding those dates from the dates on which the utility function is evaluated. Also, a delay of one day (meaning that two days are needed to survey a canton k, starting from day t) would mean that y = (I u k (t) + I u k (t + 1))/2 is measured. In other words, when there is a delay the measured quantity can still be mapped to a model quantity, which allows us to perform Bayesian inference. There are several types of measurements (Rapid testing [4] , PCR [5] , Schwabs [6] ) being proposed for testing asymptomatic individuals. We emphasize that our methodology is compatible with any of these types. Data related issues such as uncertainties, test sensitivities and delays in processing can be accommodated in the Bayesian inference framework and in the input to the SEIR model. butions. Informative data produce posterior distributions that differ from the prior; greater differences lead to higher information gain. Therefore, the most informative data y correspond to the testing strategy (measurement locations and times) with the highest information gain [7, 8] .

The OPALITS is identified by maximizing a utility function [1] . One choice 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. ;  is the KL divergence u(y, ϑ, s) = D KL p(ϑ|y, ϑ, s) p(ϑ) quantifying the information gain from the data [1] . However, since data are not available in the experimental design phase, the utility function is selected here to be the expected KL divergence E y| ϑ,s u(y, ϑ, s) over all data generated by the model prediction error equation 1. Also, to account for the uncertainty in nuisance parameters ϑ, encoded in the prior distribution p( ϑ), the expectation is also taken with respect to ϑ, which results in the utility function [1] U (s) = E ϑ E y| ϑ,s u(y, ϑ, s) = log p(ϑ|y, ϑ, s) p(ϑ) p(ϑ|y, ϑ, s) dϑ p(y| ϑ, s) dy p( ϑ)d ϑ .

By using Bayes' theorem

the utility function can be simplified to U (s) = log p(y|ϑ, ϑ, s) p(y| ϑ, s) p(y|ϑ, ϑ, s) p(ϑ) p( ϑ) dy dϑ d ϑ .

Note that the expected utility only depends on the locations and times of the measurements via s. The term p(y| ϑ, s) is the model evidence given by p(y| ϑ, s) = p(y|ϑ, ϑ, s) p(ϑ) dϑ .

The choice of the prior distribution p(ϑ) for the parameters allows to incorporate prior knowledge from epidemiology. If no information is available from data, a case encountered in the beginning of the infection, a uniform prior distribution can be assumed. In the present work, the assumed nuisance parameters are the correlation time τ and the initial condition of the unreported infections in the cantons 4 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Epidemiological Model. Here we employ the SEI r I u R epidemiological model [9] to forecast the dynamics of the coronavirus outbreak in Switzerland

where S k , E k , I r k and I u k denote the number of individuals in canton k = {1, . . . , K} that are susceptible, exposed, reported infectious and unreported infectious, respectively. We denote by K the number of cantons (26 in Switzerland), by N k the total population of the canton k, while the population mobility between cantons k and l is denoted by M kl with values obtained from the Swiss Federal Statistical Office [10] . The model parameters are the transmission rate (β), the relative transmission rate between reported and unreported infectious individuals (µ), the virus latency period (Z), the infectious period (D), the reporting rate (α) and the mobility factor (θ).

We employ different time-dependent expressions for the transmission rate and the mobility factor for each stage of the epidemic. Constants are chosen for the start of an epidemic while in the cases of monitoring of interventions, the 5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint following expressions are used: Switzerland [11] . Finally, for the third case (monitoring of a second outbreak)

we assume that After that day, the transmission rate is gradually increasing

with λ ∈ [0, 0.03], while the mobility factor regains its initial value of θ 0 . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; the expected utility is computed aŝ

In our implementation the samples ϑ (i) and ϑ Optimal Location and Time of Testing. We define the optimal survey times and locations as

where s * = (s * 1 , . . . , s * My ) with s * i = (k * i , t * i ) denote the locations k * i and times t * i for the optimal surveys with i ∈ {1, . . . , M y }. For a grid search, the associated computational cost is O((KT ) My ) and thus grows exponentially with the number of surveys. This curse of dimensionality is avoided by using a sequential optimization method [2] to approximate the global optimum by iteratively solving s * n = arg max sÛ n (s) , ∀n = 1, . . . , M y ,

where s = (k, t) is the location and time to be estimated sequentially starting with n = 1 andÛ

Following this, we define the expected information gain for survey n as

7 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint Quantification of Uncertainty. A data informed prior p(ϑ|d) of the model parameters ϑ can be computed from available data d = d 1 , . . . , d M d , collected at M d locations and days. Here, available data d refer to the daily number of reported infectious individuals and they are contrasted from the data y of the number of unreported infectious individuals. The latter are obtained from testing strategies at selected populations using optimal experimental design. The data is mapped via a distinct model output f (s, ϑ, ϑ) through the following error model

where N B is the negative binomial distribution with mean f and dispersion ν. 

The posterior distribution that will be used subsequently as a data informed prior is obtained using Bayes' theorem

and is sampled with a nested sampling algorithm [13] . Note the difference to equation 6 and the optimal testing methodology, where we are interested to reduce the uncertainty in p(ϑ|y, ϑ, s), which excludes the nuisance parameters ϑ. For the dispersion parameter in equation 18, it is assumed that ν = r f (s i , ϑ, ϑ). The coefficient r is unknown and included in the parameter set, where r ∼ U([0, 2]).

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint The marginals with a canton label XY correspond to the initial condition I u XY (t = 0) for the unreported cases in that canton.

The three inferences performed are summarized in table S5, which shows the involved model parameters in each case. The histograms for the found samples are shown in figures S1, S2, and S3.

We remark that, using the present methodology, the inferred date for the beginning of the intervention is δ 1 = 22.5, which is the 18 th of March 2020, corresponding well with the 17 th of March 2020 on which the lockdown was introduced in Switzerland [11] . Moreover, we infer a significant reduction in the mobility factor, which indicates that traffic between cantons was also minimized.

For the inference III we plot the fit using the inferred parameters in figure S4 .

The daily reported cases per canton are shown, together with the data used for the inference.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint The marginals with a canton label XY correspond to the initial condition I u XY (t = 0) for the unreported cases in that canton.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint The marginals with a canton label XY correspond to the initial condition I u XY (t = 0) for the unreported cases in that canton.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 12 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint Assume we want to estimate the proportion of a population with some margin of error d and a small risk α, i.e., we want Pr(|P − p| ≥ d) = α. Here, the proportion corresponds to the proportion of unreported infected population.

The minimum number of samples to achieve this is given by Cochran's formula [14] ,

where z α is the inverse of the standard normal cumulative distribution function evaluated at 1 − α/2. In this formula, we have assumed that the population is of infinite size. In order to correct for a finite size population N , we compute n = n 0 1 + n 0 /N .

In the next figure we present the minimum number of samples needed to sample the cantons of Switzerland for d = 0.01 and α = 0.01. Notice that α = 0.01 corresponds to a 99% confidence interval.

If the available test-kits are more than 26×5950 = 154700 then the maximum information gain will be achieved by deploying all tests uniformly in all cantons.

However, when it is not realistic to conduct over 154700 tests, we consider testing with limited resources. For example assuming 30000 available tests, will be enough to test 5 cantons 5 × 5950. The question we answer then is which 5 cantons (from the 26) should we test given that we must test a minimum population of 5950 per canton?.

Distributing less than a particular number of tests (5950) in a canton will not provide a statistically reliable estimate for the number of unreported infections there. Thus, in such a case, the measured unreported infections should not be used to estimate the expected information gain.

Finally, we note that in this work we ignore the bias in the estimate of I u . This means that the estimates of unreported infected enter the Bayesian framework without explicitly accounting for this known error.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint Table 5 : Parameters and prior distributions used in Bayesian inference. Here the data corresponds to the daily reported infections. In all cases, data are used from the 25 th of February 2020, when the first reported case was found in the canton of Ticino. Inference I uses data up to the day non-pharmaceutical interventions were announced (17 th of March 2020).

Inference II uses data up to the day measures were relaxed (6 th of June 2020). Inference III uses data up to the 9 th of July 2020. The choice of prior distributions is consistent with the choice found in [9] ; the ranges used in our study are slightly extended.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint

The copyright holder for this this version posted November 10, 2020. ; https://doi.org/10.1101/2020.11.09.20228320 doi: medRxiv preprint

Outbreak of a novel coronavirus

A review of modern computational algorithms for bayesian optimal design

Optimal sensor placement methodology for parametric identification of structural systems

The effect of prediction error correlation on optimal sensor placement in structural dynamics

COVID-19 Clinical Diagnostics and Testing Technology

Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

COVID-19 faecal-oral transmission: Are we asking the right questions? Science of The Total Environment 2020

On a measure of the information provided by an experiment

Utility theory with uncertainty

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (sars-cov-2)

Commuters for work purposes

Coronavirus: Informationen vom Bundesamtes für Gesundheit

SARS-CoV-2 Cases communicated by Swiss Cantons and Principality of Liechtenstein (FL)

Dynesty: a dynamic nested sampling package for estimating bayesian posteriors and evidences

Sampling Techniques